DrugPatentWatch Database Preview
Cadila Pharms Ltd Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?
CADILA PHARMS LTD has twenty-one approved drugs.
There is one tentative approval on CADILA PHARMS LTD drugs.
Summary for Cadila Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 19 |
| Ingredients: | 19 |
| NDAs: | 21 |
Drugs and US Patents for Cadila Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 203379-002 | Jan 4, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 211325-001 | May 13, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | NATEGLINIDE | nateglinide | TABLET;ORAL | 206432-002 | Apr 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844-003 | Feb 13, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844-004 | Feb 13, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
